Opponents argue that the science fails to support the new regulations, which would lower maximum ozone levels by a third and, for the first time, set acceptable airborne levels of fine particles less than 2.5 micrometers in diameter, called PM2.5, which are generated mainly by burning fossil fuels. Although industry groups have sharply criticized the new ozone standards, arguing that the health benefits would be marginal compared to the costs, most of the scientific debate has centered on the limits on particulate matter.
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Researchers and Lawmakers Clash Over Access to Data
I n one corner of the battleground over new clean air standards (see main text), scientists and policy-makers are skirmishing over an issue close to their hearts and pocketbooks: who "owns" raw data. Industry groups have charged that the authors of a key study on the health effects of airborne particles have resisted sharing data collected with taxpayer money-a reanalysis of which, they argue, might weaken the scientific basis of the standards. The researchers, meanwhile, are reluctant to make the data widely available because it contains confidential information on their subjects.
The fight could have repercussions that reach far beyond this year's pollution debate: A House committee earlier this month directed the Environmental Protection Agency (EPA) to publicly release raw data from air pollution research it funds. Not everyone is sure that's a good idea. "The implications of this language could be quite significant in terms of setting precedents," says Anne Sassaman, extramural grants director at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health.
The data-sharing commotion was sparked by a paper from the so-called Six Cities study, in which a Harvard team led by epidemiologist Douglas Dockery followed the health of about 8000 people over 14 to 16 years and found a link between variations in particulate matter (PM) levels and death rates. Besides tapping public databases on weather and PM levels, the researchers interviewed subjects and obtained death records. The NIEHS funded the data collection, while EPA grants paid for the analyses.
Last January, however, EPA Assistant Administrator for Air and Radiation Mary Nichols urged the Harvard group to share its data. Congress, state governors, and others had requested the raw data, the letter said, and "given the strong interest," the data "should be made available ... as rapidly as possible." Industry groups appealed to Representative Tom Bliley (R-VA), chair of the House Commerce Committee, who asked EPA and NIEHS to obtain raw data from the Six Cities study and a related Harvard study and hand it over to the committee. Given the importance and cost of the proposed rules, Bliley wrote, "it is important that the public and affected parties have the ability to review all of the underlying data ... so they can be confident that EPA is basing its decisions on sound science."
The agencies said they did not have the data, and Harvard refused to tum them over to EPA. Dockery says that subjects' medical histories and lifestyle habits, as well as death records from state and local agencies, were obtained on condition that the information would be kept confidential. Even if a subject's name were deleted from a file, Dockery says, simply knowing the date of death could be a big enough clue to identify that person, as three of the six cities in the study have populations under 50,000. The Harvard group has, however, allowed at least 18 scientists over the past 15 years to review its data collection at Harvard.
Last April, Harvard's dean for academic affairs, James H. Ware, offered a second altemative: to share the data with the Health Effects Institute, a research center in Cambridge, Massachusetts, funded by industry and the EPA, which could convene a panel of scientists not affiliated with industry or environmental groups to oversee a reanalysis. EPA agreed, and a nine-scientist panel chaired by Arthur Upton of the Robert Wood Johnson Medical School in Piscataway, New Jersey, is expected to finish its work by June 1999.
This arrangement hasn't satisfied the industry critics, however. For example, American Petroleum Institute (API) President Charles DiBona told Ware in a 1 May letter that while "we commend" Harvard for "taking this step ... we do not believe it goes far enough" and that the data should be available "for review by any professionally qualified investigators who have a legitimate scientific interest," including API. Bliley lambasted EPA again last week, saying the agency "has so far withheld the facts."
Other lawmakers are also not appeased. A report accompanying the House version of the 1998 EPA appropriations bill earmarks $35 million for particle studies that EPA would fund at NIEHS and the Department of Energy, and requires that all the data from these studies "will become available to the public, with proper safeguards" covering such issues as confidentiality, first publication rights, and scientific fraud. The Senate funding bill does not contain such a directive; thus, it may not survive a House-Senate conference later this summer to settle differences in the bills. If a data-release requirement were limited to just these studies, and if grantees were to know "up front" about the ground rules, it would not be onerous, says Sheila Newton, director of policy, planning, and evaluation for NIEHS. Some industry groups, such as the 40,000-member Small Business Survival Committee, however, are now lobbying Congress to require that data from all federally funded research be made public. That prospect concerns many researchers, who worry that wholesale release of raw data could lead to "data dredging," in which hired hands working for industry, environmental groups, or other advocacy groups might analyze it with sub-par methods to get answers favorable to their position. "There's no question that if you put in enough variables in a post hoc analysis, you can make these data or any data say whatever you want," says Dockery. "I would have deep concerns about giving up some of my data if I knew a priori someone wasn't going to do an honest job of analyzing it, if they had a political agenda," says one state scientist who asked not to be identified.
The furor has made EPA realize it needs to clarify its policy on data ownership, says Joe Alexander, acting chief of EPA's Office of Research and Development. Like most other agencies, EPA encourages extramural researchers to share data. But EPA told Bliley's committee that it almost never asks for raw data, except when investigating allegations of scientific fraud, or when data are prepared for approval of products. Alexander says one possibility under consideration is to set up a system like that at NASA, which requires agency-funded scientists to submit all their raw data. That, says Carl Mazza, science adviser in EPA's Air and Radiation Office, "would create a major issue for the way in which the scientific community operates." -J.K. Many experts, however, were skeptical of these red flags. Their main beef was that the daily mortality studies were unable to discern whether air pollution levels were significantly shortening lives or perhaps hastening by hours or days the deaths of very sick people already on the verge of dying. "People believed the studies were picking up a real phenomenon, but the interpretation was unclear," says Columbia University epidemiologist Patrick Kinney.
A more convincing set of findings came along in 1993, however, when a Harvard team headed by Douglas Dockery examined soot and other pollutant levels and 1429 deaths that occurred in 8111 adults the team followed for 14 to 16 years in six Eastern U.S. cities (known as the Six Cities study). The researchers interviewed subjects about weight, smoking, and other risk factors, correcting for these lifestyle differences, which had not been possible in earlier studies comparing city death rates. They found that the strongest association between any pollutant and death rates was with fine particles, and that the risk of death was 26% higher in the most polluted city-Steubenville--compared to the cleanest-Portage, Wisconsin. The results supported the findings of the daily studies and raised additional concerns by suggesting that the harmful effects of particles can build up over years.
A second long-term study 2 years later strengthened the case against airbome par- A Natural Resources Defense Council study extrapolated the results and came up with 64,000 annual deaths that were up to 2 years premature. Using this "body count" and its own analyses, EPA estimates that its regulations will prevent 15,000 premature deaths each year and 9000 hospital admissions, for a total estimated cost savings of$19 billion to $104 billion a year-about two to 12 times the estimated cost of compliance. Other concems center on how EPA estimated the potency of these tiny particles. Because only a few excess deaths and hospitalizations occur when the air contains low levels of particle pollution, the studies lack the statistical power to precisely estimate how dangerous particles are at these levels. So EPA assumed that the health threat increases in a linear fashion with dose, ignoring the possibility that the risk may taper off at lower levels. Adding to the uncertainty, few studies actually measured PM2.5-most used PM1o or a surrogate such as sulfates. "There's very little information on the ratio" between PM1o and PM2. Says McClellan: "We run a real hazard here of putting in place a new standard that we don't know how effective it will be."
Industry chokes on rules
A lot of hot air? EPA scientists disagree, saying they are confident that the science supports their regulations. "We think we've done a totally legitimate, rational analysis of the studies we had," says the agency's Bachmann. He points to
Puzzling Over a Potential Killer's Modus Operandi
Experts may clash over the strength of the science behind the new clean air regulations (see main text), but they do agree on one thing: It's still a mystery how airborne particles could trigger a bout of asthma or cause someone to drop dead of a heart attack. A dozen labs are now racing to find a modus operandi. This is not the first time that an unknown mechanism has bedeviled researchers trying to assess a potential environmental hazard. But unlike some other alleged risks-such as electromagnetic fields-it's apparent that the more particles one breathes, the greater the danger, says Keith Florig, a science policy expert at Carnegie Mellon University in Pittsburgh. "If you observe a strong enough dose response, that's pretty compelling," he says.
The best way to unravel a pollutant's mechanism is to study how it triggers health effects in animals. Until recently, however, researchers had drawn a blank. "I've done lots of studies" exposing healthy rats to diesel soot for nearly their entire lives at particle levels more than 10 times what people typically encounter, and "nothing happens," says toxicologist Joseph Mauderly of the Lovelace Respiratory Research Institute in Albuquerque, New Mexico.
But in a parallel to the epidemiological studies that first drew attention to the hazards of airbome particles, toxicologists in the last year or two have begun to find that sickly animals exposed to fine particles get sicker and sometimes die. For example, pulmonary biologist John Godleski of the Harvard School of Public Health in Boston found that rats with chronic bronchitis are especially vulnerable. When he exposed the animals to particles smaller than 2.5 micrometers (PM2 5) strained from Boston air, at levels equivalent to about twice the current EPA daily limit for PM1o for 6 hours per day for three straight days, 37% of the bronchitic animals died; all the healthy rats survived.
Godleski has also tightened balloons around the coronary arteries of dogs to simulate angina, or cardiac chest pain, then exposed the dogs for 6 hours to PM2.5. At particle concentrations of about 116 ,ug/m3 and 175 ig/m3, levels often reached in heavily polluted cities, the dogs' hearts developed arrhythmias that are commonly observed in people nearing a fatal heart attack. Godleski says these animal studies could help explain the observation that when particle pollution soars, "a lot of people are dying outside of the hospital. These could very well be sudden deaths" from heart attacks, he says. Now that researchers have potential animal models for the health effects, they are trying to sort out whether a particle's chemical composition dictates how dangerous it is, and how it triggers health effects. "Nobody is sure what it is in, or on, or of the particles" that causes health effects, notes toxicologist Judith Zelikoff of New York University School of Medicine. Freshly created particles appear to be more toxic than aged particles, so the culprit may be some reactive chemical groupsuch as an acid, a metal, an organic compound, or a peroxideattached to a particle's surface, says Morton Lippman, also at New York University School of Medicine. Others think that ultrafine particles, or those less than 0.1 micrometer in diameter, are the problem, because they are much more potent than larger particles at provoking immune responses in the lungs. "The problem is, none of these hypotheses really seems to be a solid explanation for all the effects," Mauderly says. "Probably they all contribute." -J.K.
what he calls "overwhelming consistency"-more than 60 of 86 population studies linked health effects to fluctuations in particulate matter levels-and the coherence between deaths, hospitalization, and respiratory disease. Others point to a study published this month in Environmental Health Perspectives by EPA researcher Tracey Woodruff and colleagues at the Centers for Disease Control and Prevention in Atlanta. They found that infants in cities with high particle pollution levels are 25% more likely to die of sudden infant death syndrome than are those in cities with relatively clean air. "It certainly adds support," says California EPA epidemiologist Bart Ostro. Schwartz also takes aim at the argument that pollutants other than particles may be blurring the picture. Cities with only one or two major airbome pollutants-such as Santa Clara, Califomia, which has low air levels of sulfur dioxide and ozone in winterstill show a link between particle levels and health problems, he says. "This whole industry argument that it's all other pollutants is just not supported by the data," says Schwartz. New York University School of Medicine epidemiologist George Thurston says "it's a valid criticism" that some of the Harvard daily city studies underestimated the effects of other pollutants, but those contributions "just reduce" the estimated danger levels of particles. "It doesn't make [the effects] go away." Finally, Bachmann says, even if PM2.5 itself is not the bad guy-if sulfates alone are the problem, for example targeting it should also control whatever pollutant is taking lives.
Most experts contacted by Science agreed that EPA was justified in setting a standard for PM2.5. "There's enough circumstantial evidence that it does make sense to begin to look at and regulate fine particles as a class," says Mauderly. At a minimum, Mauderly and others add, setting a standard will force the states to collect data that could help pin down PM2.5 health effects. But they split on just how stringent that standard should be. 
